9
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Chronic erythropoietin treatment enhances endogenous nitric oxide production in rats

, , , , , & show all
Pages 487-493 | Received 04 Feb 1997, Accepted 23 May 1997, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

N. Shimada, S. Saka, K. Sekizuka, A. Tanaka, Y. Takahashi, T. Nakamura, I. Ebihara & H. Koide. (2003) Increased Endothelin: Nitric Oxide Ratio Is Associated with Erythropoietin-Induced Hypertension in Hemodialysis Patients. Renal Failure 25:4, pages 569-578.
Read now
C. Moreau, R. Larivière, I. Kingma, J. H. Grose & M. Lebel. (2000) CHRONIC NITRIC OXIDE INHIBITION AGGRAVATES HYPERTENSION IN ERYTHROPOIETIN-TREATED RENAL FAILURE RATS. Clinical and Experimental Hypertension 22:7-8, pages 663-674.
Read now

Articles from other publishers (19)

Jerónimo Auzmendi, María B. Puchulu, Julio C. G. Rodríguez, Ana M. Balaszczuk, Alberto Lazarowski & Amalia Merelli. (2020) EPO and EPO-Receptor System as Potential Actionable Mechanism for the Protection of Brain and Heart in Refractory Epilepsy and SUDEP. Current Pharmaceutical Design 26:12, pages 1356-1364.
Crossref
Rajiv Agarwal. (2018) Mechanisms and mediators of hypertension induced by erythropoietin and related molecules. Nephrology Dialysis Transplantation 33:10, pages 1690-1698.
Crossref
Hirokazu Tsukahara. (2015) Basic and clinical research regarding vascular endothelial function. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 127:3, pages 187-195.
Crossref
Anantha Vijay R. Santhanam, Livius V. d'Uscio & Zvonimir S. Katusic. 2010. Cardiovascular Pharmacology - Endothelial Control. Cardiovascular Pharmacology - Endothelial Control 257 285 .
Noboru Toda, Kazuhide Ayajiki & Tomio Okamura. (2009) Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances. Pharmacological Reviews 61:1, pages 62-97.
Crossref
Leela Cherian, J. Clay Goodman & Claudia Robertson. (2007) Neuroprotection with Erythropoietin Administration Following Controlled Cortical Impact Injury in Rats. Journal of Pharmacology and Experimental Therapeutics 322:2, pages 789-794.
Crossref
Francis H. Verbeke, Mohsen Agharazii, Pierre Boutouyrie, Bruno Pannier, Alain P. Guérin & Gérard M. London. (2007) Local Shear Stress and Brachial Artery Functions in End-Stage Renal Disease. Journal of the American Society of Nephrology 18:2, pages 621-628.
Crossref
Anjali Desai, Ying Zhao, Heather A Lankford & Jeffrey S Warren. (2006) Nitric oxide suppresses EPO-induced monocyte chemoattractant protein-1 in endothelial cells: implications for atherogenesis in chronic renal disease. Laboratory Investigation 86:4, pages 369-379.
Crossref
Ziya Kaygisiz, Nilufer Erkasap, Nuray Yazihan, Kemal Sayar, Haluk Ataoglu, Ruhi Uyar & Murat Ikizler. (2006) Erythropoietin Changes Contractility, cAMP, and Nitrite Levels of Isolated Rat Hearts. The Journal of Physiological Sciences 56:3, pages 247-251.
Crossref
Wolfgang Jelkmann & Klaus Wagner. (2004) Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Annals of Hematology 83:11, pages 673-686.
Crossref
Bojana B. Beleslin-CokicVladan P. CokicXiaobing YuBabette B. WekslerAlan N. SchechterConstance Tom Noguchi. (2004) Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104:7, pages 2073-2080.
Crossref
Aydin Saray, Rifat Ozakpinar, Can Koc, Savas Serel, Zeynep Sen & Zeki Can. (2009) Effect of Chronic and Short‐Term Erythropoietin Treatment on Random Flap Survival in Rats: An Experimental Study. The Laryngoscope 113:1, pages 85-89.
Crossref
Huige Li, Thomas Wallerath, Thomas Münzel & Ulrich Förstermann. (2002) Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7:3, pages 149-164.
Crossref
Benjimen R. Walker, Thomas C. Resta & Leif D. Nelin. (2000) Nitric oxide-dependent pulmonary vasodilation in polycythemic rats. American Journal of Physiology-Heart and Circulatory Physiology 279:5, pages H2382-H2389.
Crossref
Emanuele Orlandi, Paolo Boselli, Roberta Covezzi, Goretta Bonaccorsi & Gian Paolo Guaraldi. (2000) Reversal of bone marrow hypoplasia in anorexia nervosa: Case report. International Journal of Eating Disorders 27:4, pages 480-482.
Crossref
Ellen S. Kang, Yu-Bo Wang, Raul Cardenas, Marjorie T. Tevlin, Sumi Mishra & Sergio R. Acchiardo. (2000) Biphasic Changes in Nitric Oxide Generation in Hemodialyzed Patients with End-Stage Renal Disease Treated with Recombinant Human Erythropoietin. The American Journal of the Medical Sciences 319:3, pages 149-157.
Crossref
EDITH BROCHU, SONIA LACASSE-M, RICHARD LARIVIÈRE, IRIS KINGMA, JOHN H. GROSE & MARCEL LEBEL. (1999) Differential Effects of Endothelin-1 Antagonists on Erythropoietin-Induced Hypertension in Renal Failure. Journal of the American Society of Nephrology 10:7, pages 1440-1446.
Crossref
Abelardo Aguilera, Rafael Selgas, M. Luisa Ruiz-Caravaca, M. Auxiliadora Bajo, M. Vicenta Cuesta, M. Angeles Plaza & Angel Hernanz. (2020) Effects of Recombinant Human Erythropoietin on Functional and Injury Endothelial Markers in Peritoneal Dialysis Patients. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19:2_suppl, pages 1-6.
Crossref
Zhenmin NiXiu Q. WangNosratola D. Vaziri. (1998) Nitric Oxide Metabolism in Erythropoietin-Induced Hypertension. Hypertension 32:4, pages 724-729.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.